Tekscan's Gait Analysis System Wins R&D 100 Award

BOSTON, Jan. 8, 2019 /PRNewswire/ -- Tekscan is thrilled to announce that StridewayTM has won an R&D 100 Award.

The R&D 100 Awards honor the latest and best innovations, identifying the top technology products of the past year. Since 1963, the R&D 100 Awards have identified revolutionary technologies introduced to the market. Learn more here.

Tekscan introduced the Strideway gait analysis system in early 2017, creating a lot of buzz with clinicians and researchers. With over twenty years of expertise developing gait analysis products, Tekscan engineers strived to simplify the gait analysis process in a modular, portable, customizable solution. Strideway is a valuable addition to an already established line of pressure measurement products, and Tekscan is proud to see that it helps so many people.

"We are so proud of the success Strideway has had since launching last year. Clinicians and researchers alike have positively responded to the Strideway form factor. Particularly with regards to its portability, simple setup, smooth surface without gait interfaces, and expanded width to accommodate a variety of patient types." – Alyssa Rubino, Tekscan Medical Product Manager

Strideway helps clinicians and researchers gain actionable insight into underlying gait abnormalities, inefficiencies, or imbalances which might otherwise go undetected. While other systems simply provide temporal and kinetic information, Strideway offers temporal, spatial, kinetic, and pressure data. Insights into areas of high pressure are particularly important to clinicians, as it can indicate areas at risk for ulceration, stress fractures, or pain points for the patient.

Strideway provides easy access to essential gait parameters from a modular tile system designed to collect the highest quality data.  The unmatched quality of data from Strideway allows clinicians and researchers to provide better care and higher quality research. To learn more about Strideway, visit the product page.

One example of the difference that Strideway can make is the case of Jimmy Gelgot, a Pennsylvania man who began suffering from an alarming loss of memory. He turned to Geisinger's Memory & Cognition Program, which utilizes Strideway for gait analysis and also as part of their overall treatment assessments.

"We can actually bring people in, have them walk on it before taking any medication, have them take the medication. An hour later we can have them walk again and we can measure scientifically how much they change or whether they change." – Dr. Glen Finney, Geisinger's Memory & Cognition Program Director

Learn more about this story here.

The R&D 100 Award Winners were selected by an independent panel of more than 50 judges representing R&D leaders in a variety of fields. Winners were recognized across five major categories—Analytical/Test, IT/Electrical, Mechanical/Materials, Process/Prototyping, and Software/Services and Other. The full list of winners can be found here.

Tekscan is honored to receive this award. We've seen the critical value that Strideway data provides to clinicians and researchers helping people around the world, and we could not be more proud.

About Tekscan, Inc.

Tekscan's patented tactile force and pressure sensing solutions provide our customers with the actionable information they need to optimize product design and improve clinical and research outcomes. Our sensors and systems are used across a wide range of applications within test and measurement, medical, dental, and retail; as stand-alone solutions or as embedded technology to create better and differentiated products. Our passion for innovation, broad expertise and commitment to quality help turn your vision into reality.

Contact:
Katrina Justiniano
Medical Marketing Program Manager
Tekscan, Inc.
Ph: +1-617-464-4500 x270,
Email: 207138@email4pr.com
www.tekscan.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/tekscans-gait-analysis-system-wins-rd-100-award-300774103.html

SOURCE Tekscan

Back to news